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Endotracheal Versus Intravenous Epinephrine During
Electromechanical Dissociation with CPR in Dogs
Sandra H Ralston, RN, PhD Willis A Tacker, MD, PhD Lee Showen, MS Alice Carter Charles F
Babbs, MD, PhD
Biomedical Engineering Center, Purdue University, West Lafayette, Indiana, USA.

ABSTRACT
The dose-response curves of epinephrine given either IV or endotracheally (ET) were compared
during resuscitation from electromechanical dissociation (EMD). Ten anesthetized dogs were
subjected to a two-minute period of electrically induced ventricular fibrillation (VF) followed by
defibrillation without CPR to produce EMD. Mechanical CPR was followed by injection of
either ET or IV epinephrine. Successful response was defined as a return of pulsatile blood
pressure within two minutes of drug administration. Using log-dose increments of epinephrine,
experimental trials were repeated in each animal. The IV and ET median effective doses were 14
and 130 g/kg, respectively. When the trials were successful, the time between drug
administration and either arterial blood pressure increases or return of spontaneous circulation
did not differ significantly for the ET and IV groups. These results show that the dosage for
epinephrine delivered ET must be higher than the IV dosage to achieve the same response during
CPR.
[Ann Emerg Med November 1985;14(11):1044-1048.]
Key words: electromechanical dissociation, epinephrine, experimental; epinephrine,
experimental, EMD, methods
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INTRODUCTION
Epinephrine has been the most thoroughly evaluated drug used in advanced cardiac life support.
A succession of studies, beginning with Crile in 1906,1 have shown repeatedly that when
epinephrine is added to resuscitation procedures following cardiac arrest, the victim's chances of
survival are improved significantly. Redding's work in the 1960s established that the value of
epinephrine lies principally in its alpha agonist activity, which produces peripheral
vasoconstriction, increased blood pressure, and improved myocardial perfusion. 2-5 The
mechanism was confirmed by subsequent research studies.6-8
Because the IV route of drug delivery may be difficult and time consuming during periods of
circulatory arrest, the American Heart Association (AHA) currently recommends that
epinephrine also be given through the endotracheal tube.9 Established protocol requires that
epinephrine be given in 0.5-mg to 1-mg doses IV and repeated at five-minute intervals until the
circulation is restored. Based on Greenberg's studies in animals with normally beating hearts,10,11
the AHA recommends that 1 mg epinephrine diluted in a 10-mL solution be given through the
endotracheal tube as an alternative to the IV route. Pilot studies in our laboratory revealed
difficulties in eliciting blood pressure responses using the recommended protocol for
tracheobronchial epinephrine administration.8 In these pilot studies, three anesthetized dogs
were subjected to electrically induced ventricular fibrillation (VF), and CPR was started
immediately. We observed no change in blood pressure following injection of endotracheal
epinephrine (0.1 mg/kg); however, deep intrapulmonary epinephrine* (0.1 mg/kg) increased the
blood pressure within a few seconds. In addition the blood pressure did not increase following
either tracheal or deep bronchial injection of epinephrine in the currently recommended doses.
These observations led us to speculate that during the low-blood-flow state that exists during
CPR, epinephrine is not absorbed readily through the conducting airways, and that the currently
recommended dosage may be too low to be effective. We therefore undertook a study to compare
the effectiveness of various doses of epinephrine given IV or endotracheally (ET) during CPR.
METHODS
Animal Preparation
Ten mongrel dogs of either sex weighing 13 kg to 29 kg (mean, 22.6 kg) were anesthetized with
IV pentobarbital sodium (30 mg/kg) and intubated with a cuffed endotracheal tube. Intravascular
catheters were placed to monitor pressures in the right atrium, aortic arch, and left ventricle. The
animals were heparinized (1 mg/kg) to retard intravascular coagulation at the catheter tips.
Physiologic monitoring was done on a Physiograph recorder (Narco Bio-systems, Houston,
Texas). Four channels of data were recorded -- ECG lead II, aortic arch pressure, central venous
pressure, and left ventricular pressure.
--------

* This technique requires a longer catheter to deposit drug much deeper into the lung substance, compared to the
endotracheal route.
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Experimental Protocol
The animal model used in our study was developed previously by Thijs and associates12 and
reproduced in studies by other investigators.13,14 The model was designed to simulate clinical
situations in which defibrillation occurs without adequate coronary perfusion, producing EMD.
VF was induced electrically using five- to ten-volt, 60-Hz electric pulses applied to the left
ventricular catheter, which contained a 0.1-mm stainless steel wire within the lumen to carry
current to the heart. After two minutes of VF, a defibrillation countershock was applied and
repeated if necessary until cardiac electrical activity resumed. During the next 30 seconds, EMD
was confirmed by observing the ECG and pressure channels to be certain that electrical activity
remained without evidence of any blood pressure pulses.
At this point, standard CPR was initiated using a mechanical Thumper ® (Michigan Instruments,
Grand Rapids, Michigan) to provide chest compressions and ventilation. After pressures were
stabilized the test drug was administered and CPR was continued. CPR was discontinued as soon
as the graphic record showed evidence of returning pulsatile blood pressure or a maximum of
two minutes after drug administration. Animals that were able to maintain their own circulation
at this time were termed successes, and those that required further help were termed failures.
Additional measures were used to resuscitate the latter group so that further experimental trials
could be performed. These measures included increasing the chest compression force to improve
CPR and/or giving intracardiac epinephrine. This experimental procedure (Figure 1) was
repeated using logarithmically incremental epinephrine doses until the animal no longer could
maintain a diastolic arterial pressure of 100 mm Hg.
Time intervals were interspersed between trials to allow for drug metabolism and animal
recovery. Following IV dosing the recovery period was 30 minutes, or more than five half-lives
of epinephrine. In the absence of pharmacokinetic studies for this endotracheal model, the
recovery period was one hour, or approximately three times longer than the time required for
blood pressure recovery to pre-fibrillation levels.
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Fig. 1. Diagrammatic representation of protocol for each experimental trial.
In order to evaluate the effectiveness of epinephrine, it is important to select an animal model in
which CPR alone is unable to restore the circulation successfully. Therefore, in the first
experimental trial each animal received saline as the test drug, and the chest compression force
was adjusted to produce a diastolic pressure of approximately 20 mm Hg. The experiment
continued only after failure to resuscitate within two minutes was confirmed using CPR and
saline. The arterial blood pressures achieved during this trial were maintained throughout
subsequent trials.
Drug Administration Techniques
Following an experimental trial using saline as the test drug, epinephrine was given as a bolus
either IV or ET, and the route was alternated in subsequent experimental trials. In half the dogs
the IV route was used first, and in the other half the ET route was used first. The initial drug
dosage for each route (10 g/kg IV or 100 g/kg diluted in 10 mL saline ET) was selected to
have a reasonable chance of success based on prior observations in other animals. Subsequent
drug dosage was based on the outcome from the first experimental trial. When the initial dose
was effective in restoring the circulation, a lower dose was then given; if ineffective, a higher
dose was used.
ET drug delivery was accomplished using a 13-F, 50-cm-long catheter equipped with a spray
nozzle on the distal tip (experimental model, Cook Inc, Bloomington, Indiana). The catheter,
which produced a fine mist spray, was advanced to a position within the trachea approximately
three inches distal to the end of the ET tube. The drug was sprayed quickly into the trachea,
followed by air injection to clear the catheter. Then two to three full, maximal ventilations were
blown into the endotracheal tube to aid in distributing the drug into the deeper airways, and CPR
as resumed.
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Data Analysis
A cumulative frequency distribution was constructed using successful resuscitations within two
minutes as the end response for each drug dose administered. In constructing these curves it was
assumed that if success had been achieved with dose, X, in a given animal, then success also
would have been achieved with doses larger than X in that animal, even though all larger doses
may not have been tested in that animal. This analytical approach is similar to that described by
Goldstein and associates for constructing dose-response curves from the distribution of drug
sensitivities.15 The median effective dose (ED50) was derived following Probit transformation of
the cumulative frequency distribution data.16
To determine further the effects of epinephrine dosage, additional variables were assessed when
the resuscitation trials were successful. These variables included the time from drug delivery to
evidence of initial blood pressure response, the time from drug delivery to return of spontaneous
circulation, the post-resuscitation peak arterial systolic and peak diastolic pressures, and the
duration of hypertension. The methods used in measuring each of these parameters are shown
(Figure 2).

Fig. 2. Physiologic tracing from a dog following epinephrine injection during CPR.
Illustrations include onset of arterial blood pressure response, onset of returning
pulsatile blood pressure, onset of hypertensive episode, and peak systolic and diastolic
arterial pressures.
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The initial blood pressure response following drug administration was defined by the intersection
of two lines drawn at the base of the control CPR pressures and at the base of the rising pressure
slope (Figure 2). The return of spontaneous circulation was coincident with blood pressure pulses
superimposed on the Thumper® -generated pulses. The duration of hypertension included the time
period when the blood pressure exceeded 140/80 mm Hg. An ANOVA was performed on these
data to test the null hypothesis that population means were equal within the groups using the
P < 0.05 level of significance.
RESULTS
In the ten animals epinephrine was given in 21 IV doses and 19 ET doses. Ten IV and nine ET
epinephrine doses were successful in promoting a return of spontaneous circulation. The
relationships between epinephrine concentration and the cumulative percentage of successful
resuscitations are shown (Figure 3). Epinephrine given by the ET route required doses that were
approximately ten times higher than the epinephrine doses required for the IV route. The IV and
ET median effective doses (ED50) were 14 g/kg and 130 g/kg, respectively.

Fig. 3. Cumulative dose-response relationships for recovery of animals following
injection of epinephrine either IV or ET.
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Blood pressures were assessed during the short period of CPR just prior to the administration of
epinephrine. Aortic diastolic pressures for the IV and ET groups were 19.9  1.02 mm Hg and
18.53  0.65 into Hg (mean  SE), respectively. The pre-drug coronary perfusion pressures
(aortic pressure minus right atrial pressure) were 7.62  0.6 mm Hg for the IV trials and 7.78 
0.65 mm Hg for the ET trials. These baseline pressures did not vary significantly between IV and
ET groups.
Evidence for early epinephrine effect was assessed by measuring the onset of blood pressure rise
and the initial evidence of spontaneous pulsatile blood pressure. There were no significant
differences between the IV and ET groups (Table) in either of these parameters. To determine
the action of epinephrine in the immediate post-recovery period, the peak arterial pressures and
the duration of the hypertensive episode were measured. Both systolic and diastolic arterial blood
pressures achieved were significantly higher following the higher-dose ET epinephrine
injections, compared with the lower doses given IV (Table). In addition the hypertensive event
lasted significantly longer following ET injection compared with IV injection of epinephrine.

DISCUSSION
The results of our study indicate that epinephrine must be given in a much higher dosage by the
ET route compared with the central venous route in order to restore circulation following cardiac
arrest associated with EMD. These results are consistent with studies by Roberts and
coworkers,10 who demonstrated blood levels of epinephrine to be ten times lower with ET
epinephrine compared with IV epinephrine. These findings suggest that the higher dose
requirement for the ET drug during CPR reflects the amount of drug actually absorbed into the
circulation by the pulmonary capillary bed. The ET-injected drug presumably remains partially
in the conducting airways, where it is poorly absorbed, particularly during the low-blood-flow
state associated with CPR. The result is an inadequate delivery of drug to the deep absorbent
surfaces of the alveolar membranes.
Evidence for this drug pool in the airways has been described in studies by Elam17 and
Roberts.10,11 Elam and coworkers described a prolonged drug effect following ET administration
that they attributed to a "depot" of drug that produced an IV drip effect delivering small
7

increments of drug over a fairly long period. Roberts and colleagues also found that ET
epinephrine significantly prolonged both the pharmacological effects and the epinephrine blood
levels compared with IV administration.
Techniques aimed at dispersing the drug more quickly into the lower airways have been
developed in the laboratory. Elam raised the animal's head 30 degrees and used a long catheter
that he moved back and forth to disperse the drug over the bronchial surfaces.17 Redding18 found
undiluted epinephrine (1 mg in 1 mL solution) given ET to be unsuccessful during resuscitation.
By diluting epinephrine in 10 mL saline or water, however, greater absorption occurred, resulting
in resuscitation successes equal to those of IV or intracardiac delivery. Greenberg and Spivey19
demonstrated the importance of forceful ventilations to maximize the distribution of drug into
the deeper lung surfaces. With the exception of raising the animals head, we used all these
techniques to maximize drug dispersion. In addition the catheter chosen for these experiments
was one capable of producing a finer spray than other currently available products. By
optimizing ET delivery we hoped to produce the optimal dose-response to epinephrine. The ET
route, however, still required epinephrine doses ten times higher than the IV route to effect
successful resuscitation.
The effectiveness of epinephrine also has been related to the timing of its delivery during the
resuscitation procedure. Redding noted that epinephrine responsiveness decreased when drug
delivery was delayed following cardiac arrest, resulting in fewer successful resuscitations.5 The
site for drug injection during CPR may play a crucial role in aiding early delivery. Previous
studies reported a more rapid onset of epinephrine effects following ET injection compared with
femoral IV injection.17 By bypassing a sluggish circulation, the ET route provided a shorter
pathway to the peripheral vasculature. In our study the onset of drug effects following ET
delivery compared favorably with the central IV route. These findings indicate that a portion of
the large ET bolus is absorbed immediately into the circulatory system.
Establishing an effective epinephrine dosage during CPR is a worthwhile yet difficult problem.
Currently the AHA recommends giving 0.5 to 1 mg (equivalent to 7.5 g/kg to 15 g/kg in a 70kg man) epinephrine IV or 1 mg ET.9 In our study, epinephrine dosages required to bring about
successful recovery of the circulation greatly exceeded the current recommendations. Four of the
successful IV doses were double the recommended human value; the nine successful ET doses
exceeded the AHA standards by factors ranging from seven to 40. Recently Kosnik and
coworkers found that centrally administered IV doses of epinephrine ranging up to ten times the
recommended dosage did not increase coronary perfusion pressures significantly in dogs during
VF and CPR.20 These findings suggest that the effective epinephrine dosage during CPR may be
higher than the current recommendations.
Additional factors influence the amount of epinephrine required to raise the arterial blood
pressure and restore the circulation. For example, the amount of blood flow generated by CPR
and the individual's responsiveness to epinephrine are two such factors. To minimize the effects
of these factors, our study compared dose-responses to ET and IV epinephrine in the same
animal using CPR that was standardized to produce comparable blood pressures during each
trial. The effectiveness of the doses reported in the study likely depends on the blood flow that
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was achieved. If the blood flow differs, the effective dose may differ. We attempted to illustrate
the differences in dose requirements for the two routes by comparing epinephrine dose-responses
in the same animal under similar conditions. Increasing the dosage of this powerful
vasoconstrictor drug may be a requirement for resuscitation success.
After the circulation is restored, however, high levels of epinephrine may produce dangerous
side effects. A period of severe hypertension that was related to the amount of the drug delivered
occurred during the recovery period. The duration of the hypertensive episode was greater when
epinephrine was given by the ET route and also was dose related. During this hypertensive
episode the already compromised heart must work against an increased afterload, causing further
damage and perhaps ultimate demise of the subject.
SUMMARY
Our study has shown that ET epinephrine dosage must be much higher than the IV dosage to
achieve the same results during resuscitation from electromechanical dissociation. When an
effective dosage is given, no difference exists between these routes in the time required to elicit a
blood pressure response or in the time to establish circulatory recovery. The hypertension
following recovery, however, is both more severe and longer lasting when these higher ET doses
are used.
The authors thank William D Voorhees, PhD, for his valuable assistance.
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